Company Search:
Advanced Search
Sponsored Links
Genomic Health, Inc. Company Snapshot
Genomic Health, Inc. operates within the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Genomic Health with three other pharmaceutical manufacturers in North America: Ionis Pharmaceuticals Inc (2015 sales of $283.70 million of which 101% was Ionis core), Neogen Corporation ($283.07 million of which 54% was Animal Safety), and 3sbio Inc ($266.08 million of which 100% was Pharmaceutical).

Sales Analysis. During the year ended December of 2015, sales at Genomic Health were $287.46 million. This is an increase of 4.3% versus 2014, when the company's sales were $275.71 million. This was the fifth consecutive year of sales increases at Genomic Health (and since 2010, sales have increased a total of 61%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Genomic Health, Inc.
  Stock Performance Chart for Genomic Health, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 29.25
(Figures in U.S. Dollars)
1 Week -0.6%   13 Weeks -5.6%  
4 Weeks -0.2%   52 Weeks -1.3%  
Genomic Health, Inc. Key Data:
  Ticker: GHDX Country: United States
  Exchanges: NAS Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2015 Sales 287,458,000
(Year Ending Jan 2016).
Employees: 802
  Currency: U.S. Dollars Market Cap: 979,268,355
  Fiscal Yr Ends: December Shares Outstanding: 33,479,260
  Share Type: Common Closely Held Shares: 929,570
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.